Thrive Wealth Management’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$299K Sell
6,411
-48
-0.7% -$2.22K 0.04% 193
2026
Q1
$317K Buy
6,459
+111
+2% +$5.16K 0.05% 174
2025
Q4
$277K Buy
6,348
+1,759
+38% +$80.3K 0.04% 191
2025
Q3
$207K Buy
+4,589
New +$202K 0.03% 229
2025
Q2
Sell
-4,541
Closed -$209K 233
2025
Q1
$209K Buy
+4,541
New +$190K 0.04% 209
2022
Q1
Sell
-5,804
Closed -$239K 158
2021
Q4
$239K Buy
+5,804
New +$219K 0.08% 131

Other funds holding EXC

Thrive Wealth Management's EXC Position: Q2 2026 in Review

Thrive Wealth Management reduced its Exelon (EXC) stake by 0.74% in Q2 2026, selling an estimated $2.22K and leaving 6,411 shares worth $299K. The position accounts for 0.04% of the portfolio, ranked #193.

Thrive Wealth Management first reported a position in EXC in Q4 2021 and has held it in 6 quarters since. The position peaked at $317K in Q1 2026. 190 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Thrive Wealth Management held 6,411 shares of Exelon worth $299K as of Q2 2026.
  • Thrive Wealth Management sold 48 Exelon shares in Q2 2026, an estimated $2.22K.
  • Exelon made up 0.04% of Thrive Wealth Management's portfolio in Q2 2026, its #193 holding.
  • Thrive Wealth Management first reported a position in Exelon in Q4 2021 and has held it in 6 quarters since.
  • Thrive Wealth Management's Exelon position peaked at $317K in Q1 2026.
  • 190 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Thrive Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.